Articles

The TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits

The TGA has issued an infringement notice for $12,600 to Labtest Direct for the alleged advertising of COVID-19 Rapid Test kits

Clinicians need to tailor the device programming of CRT-D devices to each patient to ensure the delivery of therapy

The Federal Court granted the interim injunction on 3 April 2020

Interim statement concerning the use of GS1 Australia's Recall Health platform

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page

This specification describes the minimal acceptable performance and desired features for a ventilator to be used in Australian hospitals during the current SARS-CoV2 outbreak.

The TGA has issued ATP Science Pty Ltd with 24 infringement notices

The TGA has issued Oxymed Australia Pty Ltd five infringement notices for alleged advertising breaches

The TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19

Due to changes in travel restrictions, all overseas GMP inspections and QMS audits have now been suspended until further notice

Community pharmacists to enforce new limits on dispensing and sales of prescription and over-the-counter medicines

Information for consumers

Stockpiling medicines may disrupt access to vital medicines by patients and pharmacies

Ethyl chloride spray should not be used in association with medical devices containing a common plastic

Changes to the cleaning instructions for long-term nasogastric tubes have been implemented following a TGA investigation

Patient handling slings are a vital resource to make patient transfers safer for both staff and patients, but processes must be adhered to

Health facilities and staff are reminded of the importance of following the Instructions for Use (IFU) for surgical staplers

Health professionals should be alert to the potential for false positive results and the associated risk of unnecessary patient treatment

The Secretary of the Department of Health has commenced proceedings in the Federal Court of Australia (Court) against Evolution Supplements Australia Pty Ltd

Information for cannabis manufacturers regarding TGO 93

Counterfeit medicines pose a health risk, but our tips can help you spot them.

Listed medicine ingredients and requirements have been updated.

Xofluza approved as part of an international work-sharing initiative between the TGA, Health Canada and Swissmedic

Medicines Safety Update article